Abstract Loss of Prdm16 expression in the mouse leads to a complete cleft of the secondary palate. We have now determined changes in gene expression in the secondary palates of Prdm16 −/− fetuses in an attempt to reveal the mechanism(s)
Introduction
In mice, the secondary palate develops from bilateral, medially directed outgrowths of the maxillary processes beginning on gestation day (GD)11.5. These primordia, termed palatal processes, first grow vertically on either side of the tongue until GD13.5 and consist in mesenchymal cells that are embedded in a loosely organized extracellular matrix (ECM) and enclosed within a stratified epithelium. This early development is characterized by robust cell proliferation and synthesis of ECM proteins. On GD14.0-14.5, the palatal processes undergo a series of morphogenetic movements that result in their reorientation above the tongue bringing the medial edge epithelium of each process into contact thereby forming a midline epithelial seam. The mechanisms driving this reorientation are not known but the ECM is thought to be important for this process (Morris-Wiman and Brinkley 1993) . The palatal processes then meet at the midline and fuse. The resultant medial edge epithelial seam (MES) is removed through a combination of apoptosis, cell migration and epithelial to mesenchymal transformation; however, controversy exists over the contribution of each (Jin and Ding 2006; Xu et al. 2006) . Further development of the palate consists in continued growth in order to keep pace with overall craniofacial expansion and regional differentiation into the bony (anterior) and muscular (posterior) soft palate. Disruption of any steps up to and including fusion can lead to a cleft palate.
Recent studies have demonstrated that Prdm16 gene knockout mice have a complete cleft of the secondary palate (Bjork et al. 2010) . PRDM16 is a member of a family of at least 16 structurally related proteins characterized by a PRDI-BF1 and RIZ1 homologous domain (hence its abbreviation); it has two putative DNA-binding domains and might function as a transcriptional coactivator/repressor (Kajimura et al. 2008) . PRDM16 has recently been demonstrated to be a master regulator of brown adipocyte differentiation from Myf5-positive mesenchymal precursors, leading to the inhibition of myogenic differentiation and the promotion of brown fat formation (Kajimura et al. 2008) . We have shown that PRDM16 forms a complex with both transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP)-specific Smad proteins (Warner et al. 2007) . Although the functional role of this interaction is not known, the regulation of TGF-β-and BMP-induced gene expression by PRDM16, through modulating the strength and/or extent of the response, is a possible mechanism of action.
To determine the mechanism by which PRDM16 regulates the development of the secondary palate and/or orofacial tissue, we have conducted an analysis of alterations in the expression of genes associated with the ECM, critical for the growth and elevation of the palatal processes and signaling molecules in the TGF-β/BMP signaling pathways. The TGF-β/BMP pathway was chosen because of its established importance for palate development and because PRDM16 might functionally interact to alter the patterns of expression of genes in these pathways (Warner et al. 2007 ).
Materials and methods

Animals Strain B6;129S5-Prdm16
Gt683Lex /Mmcd mice were purchased from the Mutant Mouse Regional Resource Center at the University of California at Davis and were housed in our animal facility. In this strain, Prdm16 expression was inactivated by a gene-trap that inserted the gene for β-galactosidase between exon 1 and 2. To obtain embryos/fetuses of the appropriate gestational age, a single heterozygous male was housed overnight with two nulliparous heterozygous females. The presence of a vaginal plug was taken as evidence of mating and designated GD0.5. Pregnant females were killed by CO 2 asphyxiation followed by cervical dislocation on GD11.5-15.5 and embryos/fetuses were removed and immediately chilled on ice. Limb buds were used for genotyping by using the EZ Fast Tissue/Tail PCR Genotyping Kit (EZ BioResearch, St. Louis, Mo., USA). Polymerase chain reaction (PCR) primer sequences were: wild-type, 5′ primer (5′-ACAGGCGAGGAACTGTATGAAAGG-3′); 3′ primer (5′-CCATCTGAGGTCGTCTGAAACTGG-3′); and mutant (5′-AAATGGCGTTACTTAAGCTAGCTTGC-3′). All procedures for the humane use and handling of mice were approved by the University of Louisville Institutional Animal Care and Use Committee and encompassed guidelines as set out in the EC Directive 86/609/EEC for animal experimentation.
PCR arrays
The secondary palatal shelves from GD13.5 mice were microdissected and RNA was purified by using the RNeasy RNA purification kit (Qiagen, Valencia, Calif., USA). cDNAs were synthesized and semi-quantitative real-time PCR arrays were used according to the manufacturer's instructions (SABiosciences, Frederick, Md., USA). The Sequence Detection System 7000 system from Applied Biosystems (Gaithersburg, Md., USA) was used to perform real-time PCR. The data were analyzed by using RT 2 Profiler PCR Array data analysis webbased software (SABiosciences). Three independent RNA preparations from 3-6 fetuses each were used and averaged to obtain the final results.
Reverse transcription -PCR RNA was purified from GD12.5-14.5 palatal tissue or GD11.5-15.5 mandibles from wild-type and Prdm16 −/− fetuses with the Qiagen RNeasy system (Qiagen) and cDNAs were prepared by using the Superscript II reverse transcription system (Invitrogen, Carlsbad, Calif., USA). Probe-primer pairs to specific genes were purchased from Applied Biosystems and data were normalized to the signal from the 18S ribosomal RNA gene.
Skeleton staining with alcian blue and alizarin red Mouse fetuses (6 wild-type and 3 Prdm16 −/− ) were isolated on GD14.5 and processed for cartilage and bone staining with alcian blue and alizarin red, respectively. Fetuses were skinned, fixed in 95% ethanol for 24 h, stained with 0.015% alcian blue 8GS and 0.005% alizarin red S (both from Sigma, St. Louis, Mo., USA) in 0.9 N acetic acid and 60% ethanol for 24 h at 37°C and then cleared with 1% KOH for 8 h followed by 20% glycerol/1% KOH for several days. Specimens were then processed through graded glycerol solutions before photography.
Western blotting
Secondary palate and mandible tissue was isolated from GD14.5 wild-type and Prdm16 −/− fetuses and sonicated in cell extraction buffer (Invitrogen) supplemented with protease/ phosphatase inhibitor cocktail (Roche Diagnostics, Indianapolis, Ind., USA). Total protein (40 μg) was separated on a 4%-12% acrylamide Bis-TRIS gel (Invitrogen) and electroblotted onto polyvinylidene difluoride nylon membranes (Immobilon P, Millipore, Billerica, Mass., USA). Membranes were probed with antibodies to osteopontin. This monoclonal antibody (MPIIIB10) was developed by M. Solursh and A. Franzen and was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology (Iowa City, Iowa, USA). As a loading control, blots were reprobed with a horseradish-peroxidase-conjugated rabbit monoclonal antibody to β-tubulin (Cell Signaling Technology, Danvers, Mass., USA). The protein concentration of each sample was determined by the micro-BCA assay (Thermo Scientific Pierce, Rockford, Ill., USA). Blots were developed by using the ECL Plus Western blotting detection system (GE Healthcare Lifesciences, Pittsburgh, Pa., USA). Images were collected with the ImageQuant LAS4000 biomolecular imager equipped with a 6.3 megapixel charge-coupled device camera and the data were quantitated by using ImageQuant TL 7.0 analysis software (GE Healthcare Lifesciences).
Statistical analysis
InStat3 (Graphpad Software, LaJolla, Calif., USA) was used to perform statistical tests.
Results and discussion
Differential expression of ECM genes
Mice with a deletion of the Prdm16 gene exhibit a complete cleft of the secondary palate (Bjork et al. 2010) . During normal development of the secondary palate, the palatal processes remodel to a position above the tongue on~GD14.0. In Prdm16 −/− mice, the palatal processes fail to undergo this remodeling and remain vertical lateral to the tongue. The cellular and molecular mechanism(s) underlying this phenotype are not known. Because the ECM has been shown to be important for normal palate development (de Oliveira Demarchi et al. 2010 ) and possibly for the elevation of the palatal processes (Morris-Wiman and Brinkley 1993), the expression of a panel of 84 genes associated with the ECM was determined by using a PCR-based array from SABiosciences. The complete list of genes is presented in Table S1 . Among the panel of ECM-associated genes analyzed, only four were differentially expressed in Prdm16 −/− palatal tissue when compared with wild-type palates (Table 1) . These four genes, each of which was expressed at a higher level in Prdm16 −/− palatal tissue, were Col2a1, Hapln1, Mmp-11 and Sgce; however, only the expression of Hapln1 reached statistical significance (P<0.05, one-way analysis of variance [ANOVA] ).
Differential expression of TGF-β/BMP signaling pathway genes
Several of the major signaling pathways important for embryonic development have been directly shown to play a role in −/− fetuses on gestation days (GD) 12.5-14.5 and cDNAs were synthesized. The expression of the indicated genes was determined by semiquantitative real-time PCR (Taqman) with pre-designed probe/primer sets from Applied Biosystems and represent genes from early (proliferation/condensation), mid (differentiation) and late (ossification) events during chondro-/osteogenesis. Data were normalized to the expression of the 18S rRNA gene and are expressed as fold-changes± SD compared with the expression on GD12.5 (n03). *P<0.01 (+/+ vs. −/−; one-way ANOVA) (nc no change) Gene GD13.5 GD14.5 normal palate development in mice. Of these, the pathway activated by the gene superfamily that includes TGF-β and BMP has been studied the most thoroughly to date and each has been shown to regulate ECM metabolism (Roberts et al. 1986; Shum et al. 2003) . Additionally, PRDM16 has been shown to bind to both TGF-β and BMP-linked Smads (Warner et al. 2007) , thereby potentially regulating the transcription of downstream genes. Therefore, the expression of a panel of 84 genes linked to these two signaling pathways was determined by PCR array analysis. The complete list of genes is presented in Table S2 . The expression of five genes was increased more than 1.5-fold in palatal tissue from Prdm16 −/− mice compared with wild-type littermates (Table 2 ). These genes include Bmp1, Gdf7 (Bmp12), Gdf6 (Bmp13), Gsc and Il-6. All increases, with the exception of Bmp1, were statistically significant when compared with wild-type levels (Gdf6 and Il-6, P<0.05; Gdf7 and Gsc, P<0.01, one-way ANOVA).
Differential expression of genes linked to chondrogenesis and osteogenesis in the secondary palate
Because the genes that exhibited changes in expression in Prdm16 −/− palatal tissue had in common a role in chondroand/or osteogenesis, the expression of additional genes important for these two processes was also determined. Genes selected for analysis were categorized as being involved in early (Sox9, Col2a1), mid (Acan, Has2, Runx2, Shox2) and late (Osx, Opn, Akp) stages of chondro-and osteogenic differentiation (Goldring et al. 2006) . The data are presented as the gene expression level in wild-type or Prdm16 −/− palatal tissue on either GD13.5 or GD14.5 relative to the expression level on GD12.5 (Table 3 ). The largest change in expression was found for Col2a1, Osx, Shox2 and Opn, with the remainder of the genes tested displaying little differences between wild-type and Prdm16 −/− samples. In wild-type samples, the expression of Col2a1 was increased by 4.9±0.6-fold on GD13.5 (compared with GD12.5) and by 2.8±0.5-fold on GD14.5. In Prdm16 −/− samples, Col2a1 expression was significantly higher than wildtype levels on both GD13.5 and GD14.5 (>40-fold and >25-fold, respectively). Conversely, whereas Osx expression in Prdm16 −/− fetuses was elevated when compared with GD12, expression was significantly less on GD13.5 and GD14.5 in samples from Prdm16 −/− fetuses when compared with wildtype. The expression of Shox2 in Prdm16 −/− samples was twofold higher on GD13.5 and almost three-fold higher on GD14.5. Finally, the expression of Opn was significantly less on GD14.5 in Prdm16 mutant palates with no significant difference being observed on GD13.5. Therefore, the expression of two genes important for early and mid stages of chondrogenesis (Col2a1 and Shox2) were both significantly increased, Mandibles were dissected on GD11.5-GD15.5 from wild-type and Prdm16 −/− embryos/fetuses, RNA prepared and cDNAs synthesized and analyzed by real-time PCR for the expression of early (proliferation/condensation), mid (differentiation) and late (ossification) processes of chondro/osteogenesis. The data are expressed as the relative level (mean±S.D.) on days 12.5-15.5 of gestation compared to the level on day 11.5 *P<0.01, one-way ANOVA. The data are representative of 2 independent sets of samples assayed in triplicate whereas two gene markers for later stages (Osx and Opn) were decreased. PRDM16 might indirectly regulate the expression of these genes because a recent study to identify gene targets in palate mesenchymal cells by ChIP-Chip failed to identify any of these genes (Warner et al. 2012) . However, in that study cultured palate mesenchymal cells were used and we might not have identified all genes regulated by PRDM16 in the intact secondary palate. Further experiments will be needed to determine whether any of these genes are directly regulated. In addition, the concomitant rise in expression of both Col2a1 and Shox2 are unlikely to be linked, because in Shox2 knockout mice no change was detected in the expression or distribution of Col2a1 (Cobb et al. 2006) . In this same report, Shox2 was shown to be upstream of Runx2. However, we saw no change in the expression of the latter in palate tissue (Table 3 ). The simultaneous decrease in Osx and Opn expression may nevertheless be linked. Nakashima et al. (2002) found that Opn expression in the periosteum bone layer was decreased in Osx-null mouse mutants.
Prdm16 knockout leads to altered mandibular chondrogenesis and osteogenesis
In addition to cleft palate, Prdm16 −/− fetuses also have a smaller mandible (Bjork et al. 2010) . Because proper development of the mandible is also important for repositioning of the tongue to allow the palatal processes to remodel, make contact and fuse, we performed an analysis, similar to that described above for palatal tissue, of the expression of genes important for all stages of chondrogenesis and osteogenesis in GD11.5-15.5 mandibles from wild-type and Prdm16 −/− embryos/fetuses. These data are reported in Table 4 . Genes important for early (Col1a1, Col2a1, Sox9), mid (Runx2, Acan, Lp-1, Has-2, Shox2) and late (Osx, Satb2, Opn, Akp) stages of chondro-and osteogenic differentiation were analyzed. The expression Col1a1, an early marker of chondrogenesis, was increased in mandible tissue of Prdm16 −/− fetuses on GD13.5 and GD15.5, compared with levels in wildtype tissue. With the exception of Has-2 and Shox2, an increase occurred in the expression of markers for processes involved in mid-phases of chondrogenic determination in Prdm16 −/− mandibular tissue. Has-2 expression levels were not altered; however, Shox2 levels were reduced on GD12.5, GD14.5 and GD15.5 in Prdm16 −/− mandibular tissue. Runx2, Acan and LP-1 levels were significantly elevated in Prdm16 −/− mandibular tissue, particularly on GD15.5. Finally, the late markers, Osx and Opn, were significantly reduced in Prdm16 −/− mandibular tissue, relative to wild-type levels (Osx, on GD15.5); however, the expression of Akp was more complex, increasing on GD12.5, decreasing on GD13.5 and GD15.5 and with no significant change on GD14.5. The premature elevation of many of these markers suggests that the normal program of chondrogenesis was perturbed leading to the stunted forward expansion of Meckel's cartilage.
Western blot analysis of the expression of osteopontin in the GD14.5 palate and mandible tissue was performed to Fig. 1 Western blot analysis of the expression of OPN in mouse fetal palate and mandible tissue. Prdm16 −/− and wild-type palate and mandible tissue was dissected from GD14.5 fetuses and processed for Western blot. a Expression of OPN and β-tubulin (loading control) in secondary palate tissue lysates. Four separate fetuses were analyzed for each genotype. The bar graph represents the quantitation of the expression of OPN relative to that of β-tubulin. In palate tissue isolated from Prdm16 −/− fetuses, the expression of OPN was reduced by~30% compared with wild-type tissue. b Expression of OPN in GD14.5 mandible lysates. Four wild-type and five Prdm16 −/− fetuses were collected and analyzed. Although the expression levels of OPN were variable in Prdm16 −/− fetuses, a significant decrease in expression was seen. The bar graph demonstrates that the normalized expression of OPN was reduced by~50 % in Prdm16 −/− mandible tissue. For each graph, the data are presented as the mean±SD of 4-5 fetuses. *P<0.05, one-way ANOVA determine whether protein levels reflected the decrease in mRNA expression. As expected from the reverse transcirption-PCR (RT-PCR) experiments, the expression of OPN was reduced in Prdm16 −/− palate tissue compared with wild-type levels (Fig. 1a) . In order to quantitate the extent of the decrease, the blots were probed with antibodies to β-tubulin and the signal from OPN was normalized to that from β-tubulin (presented in the bar graph in Fig. 1a) . By RT-PCR, the expression of OPN was decreased~45% in Prdm16 −/− palate tissue (Table 3 ) and by~30% by Western blot. In mandible tissue, although some variation occurred in the expression of OPN in Prdm16 −/− fetuses, on average, a 50% decrease was detected in the signal (Fig. 1b) compared with a~20% decrease by RT-PCR (Table 4) . Therefore, a late marker for chondrogenesis was found to be decreased at the mRNA and protein levels. Furthermore, we recently demonstrated that the expression of Opn was also reduced in Prdm16 −/− palates as assayed by RNA in situ hybridization (Warner et al. 2012) .
We also performed skeletal staining of GD14.5 fetuses with alcian blue (cartilage) and alizarin red (bone) (Fig. 2) . Because little osteogenesis occurs on GD14.5, no alizarinred-positive ossification centers were observed. In addition to a generalized reduction in alcian blue staining in forming cranial bones (parietal and temporal, for example), a significant reduction in both chondrogenesis and the anterior growth of Meckel's cartilage was found in Prdm16 −/− fetuses (Fig. 2b, red arrow) .
Prdm16 −/− mice have a cleft palate because of failure of the palatal processes to reorient. The underlying mechanism for this phenotype is not, however, known but has been suggested to involve alterations in TGF-β signaling (Bjork et al. 2010 ). On GD12.5 and GD13.5, the palatal processes from wild-type and Prdm16 −/− mice are morphologically similar (i.e., are of comparable size and shape) with stark differences only being apparent beginning on GD14.5 (data not shown). ECM synthesis is critical for the elevation of the palatal processes (Morris-Wiman et al. 2000) . We found that the expression of several genes linked to the ECM was increased. Col2a1 is known to be involved in chondrogenesis and knockout mice have a cleft palate (Barbieri et al. 2003) . The significantly increased expression of Col2a1 in Prdm16 −/− mice suggests that PRDM16, directly or indirectly, represses its synthesis. Because the expression of Prdm16 decreases from GD12.5 to GD14.5, one function might be to prevent the premature synthesis of Col2a1 and/or to limit the extent of synthesis. The significance of Mmp11 upregulation in Prdm16 −/− palate tissue is not known, as no direct link has been established with chondro-or osteogenesis. Interestingly, Sgce has been found in both −/− (−/−) and wild-type (+/+) fetal heads stained with alcian blue and alizarin red and cleared. Reduced chondrogenesis is evident in the nasal cartilage (nc), parietal bone (p), temporal bone (tem) and Meckel's cartilage (mc) of Prdm16 −/− fetuses. Significant reduction in the length of Meckel's cartilage is also apparent. b Frontal view of the same specimens as in a illustrating the lack of fusion of Meckel's cartilage in Prdm16 −/ − fetuses at the anterior-most aspect (red arrow) and an overall reduced intensity of alcian blue staining. Bars 1 mm white adipocytes and in skeletal muscle (Groh et al. 2009 ) and as for Mmp11, no direct role in palate development has been identified.
The TGF-β/BMP family is essential for secondary palate development as revealed by several mouse knockout models (Baek et al. 2011; Proetzel et al. 1995; Xu et al. 2006 ). Because we have previously shown that PRDM16 interacts with TGF-β/BMP-regulated Smads, it might mediate the signaling activity of these cytokines. Indeed, in Prdm16 −/− mice, the expression of several TGF-β/BMP-regulated genes was dysregulated, including Gdf6 and Gsc, both of which have been linked to skeletal development, with the precise control of expression of the latter being critical because either knockout (Rivera-Perez et al. 1995) or overexpression (Boucher et al. 2000) leads to craniofacial defects, including cleft palate. Additionally, Il-6 (increased in Prdm16 −/− mice) has been shown to inhibit the expression of Col2a1 and Acan expression in ATDC5 chondrogenic precursor cells (Nakajima et al. 2009 ).
The reason that the expression of some genes essential for chondrogenesis is increased (Col2a1, Shox2), whereas that of others is decreased (Osx, Opn) and the impact that this has on the developing palate remain unclear. Based on work published by Yu et al. (2005) on a conditional knockout of Shox2 expression in the secondary palate, the expression of Runx2 and Osx is decreased, suggesting that the genes are downstream targets. If this were true, one would expect that expression should increase when Shox2 is overexpressed (as observed in Prdm16 −/− palate tissue). However, no effect on the expression of Runx2 and a decreased expression of Osx were detected. The combined effect of the loss of Prdm16 expression with the elevated Shox2 (and other genes) possibly accounts for the unexpected results. Alternatively, these genes might be directly regulated by PRDM16. Based upon these results, we propose the hypothesis that PRDM16 regulates the expression of key genes important for the chondrogenic differentiation of palate mesenchymal cells and, potentially, the inhibition of myogenic differentiation in the anterior palate. The expression of myogenin was increased in Prdm16 −/− palate tissue (Table 4) . Loss of Prdm16 expression might lead to disturbances in the constitution of the ECM to such an extent that normal palatal morphogenetic movements do not occur properly and/or that the underlying signaling pathways are altered (e.g., TGF-β/BMP). In addition to affecting the normal development of the secondary palate, the loss of Prdm16 expression also disrupts mandibular development by altering the expression of a similar panel of genes to that in the palate. Recently, Bjork and colleagues (2010) have suggested that, during the development of the mandible in Prdm16 knockout mice, ossification increases. In our analysis, however, we have found no evidence of an increase; rather, we have observed a generalized decrease in bone maturation (Fig. 2) . The defects in mandibular development might contribute to the cleft palate phenotype in Prdm16 −/− fetuses by not allowing the proper repositioning of the tongue so that the shelves elevate properly; however, additional experiments are required to test this hypothesis. We are currently working to dissect the contributions from altered mandibular development and defects in signaling mechanisms intrinsic to the secondary palate and resulting from the loss of Prdm16 expression.
